BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28296079)

  • 41. Impaired hypothalamic regulation of endocrine function and delayed counterregulatory response to hypoglycemia in Magel2-null mice.
    Tennese AA; Wevrick R
    Endocrinology; 2011 Mar; 152(3):967-78. PubMed ID: 21248145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways.
    Wijesuriya TM; De Ceuninck L; Masschaele D; Sanderson MR; Carias KV; Tavernier J; Wevrick R
    Hum Mol Genet; 2017 Nov; 26(21):4215-4230. PubMed ID: 28973533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regionally reduced brain volume, altered serotonin neurochemistry, and abnormal behavior in mice null for the circadian rhythm output gene Magel2.
    Mercer RE; Kwolek EM; Bischof JM; van Eede M; Henkelman RM; Wevrick R
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1085-99. PubMed ID: 19199291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Spectrum of the Prader-Willi-like Pheno- and Genotype: A Review of the Literature.
    Juriaans AF; Kerkhof GF; Hokken-Koelega ACS
    Endocr Rev; 2022 Jan; 43(1):1-18. PubMed ID: 34460908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Prader-Willi syndrome murine imprinting center is not involved in the spatio-temporal transcriptional regulation of the Necdin gene.
    Watrin F; Le Meur E; Roeckel N; Ripoche MA; Dandolo L; Muscatelli F
    BMC Genet; 2005 Jan; 6():1. PubMed ID: 15634360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of Prader-Willi Syndrome gene MAGEL2 in severe childhood-onset obesity.
    O'Neill MA; Farooqi IS; Wevrick R
    Obes Res; 2005 Oct; 13(10):1841-2. PubMed ID: 16286533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of oxytocin on neurite outgrowth and synaptic proteins in Magel2-deficient mice.
    Reichova A; Schaller F; Bukatova S; Bacova Z; Muscatelli F; Bakos J
    Dev Neurobiol; 2021 May; 81(4):366-388. PubMed ID: 33609001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.
    Igarashi M; Narayanaswami V; Kimonis V; Galassetti PM; Oveisi F; Jung KM; Piomelli D
    Pharmacol Res; 2017 Mar; 117():75-81. PubMed ID: 28007570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader-Willi syndrome.
    Bittel DC; Kibiryeva N; McNulty SG; Driscoll DJ; Butler MG; White RA
    Am J Med Genet A; 2007 Mar; 143A(5):422-9. PubMed ID: 17036336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioural and cognitive abnormalities in an imprinting centre deletion mouse model for Prader-Willi syndrome.
    Relkovic D; Doe CM; Humby T; Johnstone KA; Resnick JL; Holland AJ; Hagan JJ; Wilkinson LS; Isles AR
    Eur J Neurosci; 2010 Jan; 31(1):156-64. PubMed ID: 20092561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal analysis of electroencephalography pattern changes in an infant with Schaaf-Yang syndrome and a novel mutation in melanoma antigen L2 (MAGEL2).
    Mizuno S; Yokoyama K; Yokoyama A; Nukata T; Ikeda Y; Hara S
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1932. PubMed ID: 35343647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MAGEL2 (patho-)physiology and Schaaf-Yang syndrome.
    Schubert T; Schaaf CP
    Dev Med Child Neurol; 2024 Jul; ():. PubMed ID: 38950199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magel2 is required for leptin-mediated depolarization of POMC neurons in the hypothalamic arcuate nucleus in mice.
    Mercer RE; Michaelson SD; Chee MJ; Atallah TA; Wevrick R; Colmers WF
    PLoS Genet; 2013; 9(1):e1003207. PubMed ID: 23341784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The N-terminal domain of the Schaaf-Yang syndrome protein MAGEL2 likely has a role in RNA metabolism.
    Sanderson MR; Fahlman RP; Wevrick R
    J Biol Chem; 2021 Aug; 297(2):100959. PubMed ID: 34265304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in genetic mechanisms of hypothalamic dysfunction in Prader-Willi syndrome.
    Wang XY; Sun R; Gao YQ
    Yi Chuan; 2022 Oct; 44(10):899-912. PubMed ID: 36384726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MAGEL2 and Oxytocin-Implications in Prader-Willi Syndrome and Beyond.
    Fountain MD; Schaaf CP
    Biol Psychiatry; 2015 Jul; 78(2):78-80. PubMed ID: 26092431
    [No Abstract]   [Full Text] [Related]  

  • 57. Loss of Magel2 impairs the development of hypothalamic Anorexigenic circuits.
    Maillard J; Park S; Croizier S; Vanacker C; Cook JH; Prevot V; Tauber M; Bouret SG
    Hum Mol Genet; 2016 Aug; 25(15):3208-3215. PubMed ID: 27288456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxytocin receptors in the Magel2 mouse model of autism: Specific region, age, sex and oxytocin treatment effects.
    Gigliucci V; Busnelli M; Santini F; Paolini C; Bertoni A; Schaller F; Muscatelli F; Chini B
    Front Neurosci; 2023; 17():1026939. PubMed ID: 36998737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic analysis of the chromosome 15q11-q13 Prader-Willi syndrome region and characterization of transcripts for GOLGA8E and WHCD1L1 from the proximal breakpoint region.
    Jiang YH; Wauki K; Liu Q; Bressler J; Pan Y; Kashork CD; Shaffer LG; Beaudet AL
    BMC Genomics; 2008 Jan; 9():50. PubMed ID: 18226259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model.
    Borie AM; Dromard Y; Guillon G; Olma A; Manning M; Muscatelli F; Desarménien MG; Jeanneteau F
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33232306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.